Inclusion of key populations in clinical trials of new antituberculosis treatments: Current barriers and recommendations for pregnant and lactating women, children, and HIV-infected persons
Amita Gupta(Johns Hopkins University), Anneke C. Hesseling(Desmond Tutu HIV Foundation)
Cited by 45
Related Papers
Gender-Related Barriers and Delays in Accessing Tuberculosis Diagnostic and Treatment Services: A Systematic Review of Qualitative Studies
|Tuberculosis Research and Treatment|2014|95
Protecting children in low-income and middle-income countries from COVID-19
|BMJ Global Health|2020|46